Skandinaviska Enskilda Banken (SEB)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $1.02M | Hold |
|
|||||
|
2025
Q1 | $855K | Hold |
|
|||||
|
2024
Q4 | $859K | Hold |
|
|||||
|
2024
Q3 | $867K | Hold |
|
|||||
|
2024
Q2 | $705K | Hold |
|
|||||
|
2024
Q1 | $579K | Sell |
|
|||||
|
2023
Q4 | $1.14M | Hold |
|
|||||
|
2023
Q3 | $1.35M | Hold |
|
|||||
|
2023
Q2 | $1.34M | Buy |
|
|||||
|
2023
Q1 | $788K | Sell |
|
|||||
|
2022
Q4 | $1.14M | Sell |
|
|||||
|
2022
Q3 | $1.32M | Hold |
|
|||||
|
2022
Q2 | $1.11M | Hold |
|
|||||
|
2022
Q1 | $1.71M | Hold |
|
|||||
|
2021
Q4 | $1.45M | Hold |
|
|||||
|
2021
Q3 | $1.51M | Buy |
|